NOTE! This site uses cookies and similar technologies.

If you not change browser settings, you agree to it. Learn more

I understand

15th Meet The Professor

Advanced International Breast Cancer Course (AIBCC)

Padua, October 10th - 12th 2019



11,9

points

  • Presentation
  • Directors
  • Scientific Committee
  • Speakers & Chairmen
  • Program
  • Poster session
  • Registration
  • Slide Kit

Aims

Mortality from breast cancer is declining in most countries thanks to effective screening programs, early diagnosis, molecular characterization of the different subtypes and biology-driven treatments. A multidisciplinary management of breast cancer patients is therefore the key to success and a breast multidisciplinary team should include - besides the “classic” clinical specialties - pathologists, molecular biologists and oncogeneticists. Furthermore, the availability of multiple diagnostic and therapeutic choices, the increasing costs of new technologies and drugs and the issue of sustainability represent a new challenge for socially-responsible clinicians. With this goal in mind, the Programme includes lectures on molecular characterization, updated treatments of early and advanced disease, management of difficult cases and hereditary syndromes.

Clinical case discussions and debates are planned to allow a continuous and fruitful exchange of experiences and opinions between speakers and participants.

This 15th Breast Cancer Conference includes highly qualified international faculty, but will maintain its characteristics of a friendly forum where opinion leaders and attendees might exchange experiences and share the most exiting advances.

In order to reward scientific excellence and to foster international cooperation, the International Scientific Committee of the 15th AIBCC will award the 9th International Prize for Breast Cancer Research to a scientist who has published a breakthrough paper in the previous year. We also welcome the presentation of posters from participants and the best poster will be awarded during the Award Ceremony.

The Conference is addressed to medical oncologists, pathologists, breast surgeons, radiation oncologists and basic scientists who will have the opportunity to interact with breast cancer leaders and exchange experiences in a friendly atmosphere.

Addressed to

Gynaecologists and obstetrics, medical oncologists, pathologists, radiologists, radiation oncologists, surgeons. Biologists, pharmacists, and nurses.

 

CME

Based on Italian regulations, Accademia Nazionale di Medicina (provider n. 31) will assign to the activity CME (31-265479): 11,9 CME points.

 

The credit certification is subject to:

  • Professions/specializations should correspond to those which have been accredited for CME;
  • 90% attendance to the meeting;
  • Completion of the meeting evaluation form;
  • Completion of the final questionnarie (at least 75% of correct answers).

We would like to remind you to participants that only 1/3 of CME credits acquired during the years 2017/2019 can come from a sponsorship.

 

Official Language

The official language of the Meeting is English. No simultaneous translation will be provided.

Foto

Pier Franco Conte

Division of Medical Oncology 2

Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology
and Gastroenterology
University of Padua (I)

Foto

Gabriel N. Hortobagyi

Department of Breast Medical Oncology

The University of Texas - MD Anderson Cancer Center
Houston (USA)

Hesham Ahmed Gaballah Elghazaly

Department of Clinical Oncology and nuclear medicine
University of Ainshams
Cairo (EG)

Valentina Guarneri

Division of Medical Oncology 2
Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Jacek Jassem

Department of Oncology and Radiotherapy
Medical University of Gdansk (PL)

Stephen Johnston

NIHR Biomedical Research Centre for Cancer
Royal Marsden NHS Foundation Trust & Institute of Cancer Research
London (UK)

Sibylle Loibl

German Breast Group
University of Frankfurt (D)

Eleuterios Mamounas

Comprehensive Breast Program
MD Anderson Cancer Center Orlando
Orlando (F)

Miguel Martin

Medical Oncology Service
Hospital Universitario Gregorio Marañon
Madrid (E)

Stefania Migliuolo

Europa Donna Italia
Milan (I)

Fedro Alessandro Peccatori

Department of Medical Oncology
European Institute of Oncology (IEO)
Milan (I)

Philip Poortmans

President of ECCO
Department of Radiation Oncology
Institut Curie
Paris (F)

Aleix Prat

Medical Oncology Department
Hospital Clinic
Barcellona (E)

Matti S. Aapro

Multidisciplinary Oncology Institute
Clinique De Genolier
Genolier (CH)

Alessandra Andrisani

Department of Women's and Children's Health
University of Padua (I)

Laura Biganzoli

Breast Unit
Prato Hospital
AUSL Toscana Centro
Prato

Giuseppe Buono

Oncology Unit
A.O.U. Federico II
Napoli (I)

Riccardo Caccialanza

Dietetics and Clinical Nutrition Service
IRCCS Policlinico San Matteo
Pavia (I)

Luisa Carbognin

Medical Oncology Unit
G.B. Rossi Hospital
Verona (I)

Francesca Caumo

Radiology Unit
Istituto Oncologico Veneto IRCCS
University of Padua (I)

Giuseppe Curigliano

Department of Oncology
European Institute of Oncology
University of Milan (I)

Maria Vittoria Dieci

Division of Medical Oncology 2
Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Maia Dzhugashvili

Department of Radiation Oncology
Instituto Madrileño de Oncología (Grupo IMO)
Murcia (E)

Sabrina Fontana Kahler Ribeiro

Unit of Molecular Senology
European Institute of Oncology
Milan (I)

Viviana E. Galimberti

Unit of Molecular Senology
European Institute of Oncology
Milan (I)

Marco Gambacciani

Obstetrics & Gynecology Unit
S. Chiara Hospital
Pisa (I)

Carlo Alberto Giorgi

Division of Medical Oncology 2
Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Gaia Griguolo

Division of Medical Oncology 2
Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Claudine Isaacs

Cancer Center
Georgetown University
Washington (USA)

Federica Miglietta

Division of Medical Oncology 2
Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Marco Montagna

Hereditary Tumors Group Breast and Ovary Cancer
Department of Oncological Molecular Diagnostic and Immunology
Istituto Oncologico Veneto
University of Padua (I)

Mafalda Oliveira

Medical Oncology Department; Breast Cancer Group
Vall d'Hebron University Hospital; Vall d'Hebron Institute of Oncology (VHIO)
Barcellona (S)

Emanuela Olmetto

Department of Radiation Oncology
Careggi Hospital
Firenze (I)

Enrico Orvieto

General Pathology and Cytopatology Unit
Department of Medicine-DIMED
University of Padua (I)

Giacomo Pelizzari

Medical Oncology
Oncology Center
Aviano (I)

Giancarlo Pruneri

Department of Patholgy 2
Fondazione IRCCS Istituto Nazionale dei Tumori
Milano

Hope Rugo

UCSF Carol Franc Buck Breast Care Center
Breast Oncology Clinical Trials Program
San Francisco (USA)

Tania Saibene

Breast Surgery
Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Roberto Salgado

Department of Pathology, GZA-ZNA, Antwerp, Belgium
Division of Research, Peter Mac Callum Cancer Centre, Melbourne, Australia

Peter Schmid

Centre for Experimental Cancer Medicine Bart Cancer
Institute Queen Mary University
London (UK)

Sandra Swain M.

Research Development
Georgetown University Medical Center
Washington (USA)

Vassilena Tsvetkova

Division of Medical Oncology 2
Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Stefania Zovato

Familial Cancer Clinic
Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and Gastroenterology
Padova (I)

Thursday, October 10th

8.30

Registration

9.15

 

Introduction to the Conference
Pierfranco Conte, Gabriel N. Hortobagyi

9.30

Lecture
Essential requirements for quality of care in breast cancer

Laura Biganzoli

SESSION I - PREVENTION AND SCREENING: FROM LIFE-STYLE TO MULTIGENE PANELS
Chairmen: Francesca Caumo, Stefania Zovato

10.00

Diet: myths and facts
Riccardo Caccialanza

10.20

Chemoprevention: how scientific evidence is applicable in daily practice
Claudine Isaacs

10.40

The wave of multigene panels
Marco Montagna

11.00

Personalized screening
Francesca Caumo

11.20

Q&A

11.30

Coffee break

 

SESSION II - LOCOREGIONAL TREATMENT
Chairmen: Jacek Jassem, Claudine Isaac

11.50

De-escalating surgery for breast cancer: the surgeon’s point of view
Viviana E. Galimberti

12.10

De-escalating surgery for breast cancer: the oncologist’s point of view
Gabriel N. Hortobagyi

12.30

Radiation therapy: updates
Philip Poortmans

12.50

Q&A

13.00

Lunch

14.00

Multidisciplinary Tumor Board 1 – Locoregional treatment
Chairmen: Viviana E. Galimberti

  • Clinical case: Margins in DCIS
    Tania Saibene
  • Clinical case: BLS before/after neoadjuvant therapy
    Sabrina Fontana Kahler Ribeiro
  • Clinical case: Partial breast irradiation
    Emanuela Olmetto
  • Concluding comments
    Viviana E. Galimberti

SESSION III – LIFE AFTER BREAST CANCER
Chairmen: Alessandra Andrisani, Stefania Migliuolo

15.30

Gynecologic consequences
Marco Gambacciani

15.50

Cognitive consequences
Matti Aapro

16.10

Social impact
Stefania Migliuolo

16.30

Pregnancy and fertility
Fedro Peccatori

16.50

Q&A

17.00

COFFEE WITH PROFESSORS - Career Development

  • Clinical research in Breast Cancer: medical oncology
    Pierfranco Conte, Gabriel N. Hortobagyi
  • Clinical research in Breast cancer: surgery and radiotherapy
    Viviana E. Galimberti, Philip Poortmans
  • Translational research in breast cancer
    Mafalda Oliveira, Aleix Prat

18.00

Adjourn

Friday, October 11th

8.00

Poster display

 

SESSION IV – PATHOLOGY, GENOMICS & MOLECULAR BIOLOGY
Chairmen: Enrico Orvieto, Aleix Prat

9.00

PDL1 test in breast cancer: which, when and why?
Giancarlo Pruneri

9.20

Tumor infiltrating lymphocytes in breast cancer: role in clinical practice
Roberto Salgado

9.40

Clinical impact of genomics for HER2+ and TNBC
Aleix Prat

10.00

Prognostic multigene assays for HR+ breast cancer: who are the patients to be tested?
Maria Vittoria Dieci

10.20

Q&A

10.40

Coffee break

 

SESSION V – SYSTEMIC TREATMENTS FOR EARLY BREAST CANCER
Chairmen: Stephen Johnston, Gabriel N. Hortobagyi

11.00

Neoadjuvant therapy: values and pitfalls
Valentina Guarneri

11.20

Enhancing chemotherapy for early TNBC: the debate around platinum and capecitabine
Hope Rugo

11.40

More or less chemotherapy? Role of anthracycline in the era of personalized medicine
Miguel Martin

12.00

Enhanced endocrine therapy: who needs extended endocrine therapy?
Stephen Johnston

12.20

Enhanced endocrine therapy for premenopausal patients: OFS plus what?
Sybille Lobil

12.40

Q&A

13.00

Lunch

14.00

Multidisciplinary Tumor Board 2 - Early breast cancer: challenging cases for pathologists and clinicians
Chairmen: Giancarlo Pruneri
Panelists: Gabriel N. Hortobagyi, Sybille Lobil, Miguel Martin, Enrico Orvieto, Aleix Prat

  • Clinical case: “rare” HER2 ISH patterns (i.e. ratio >2.0 with HER2 copies <4; ratio<2.0 with HER2 copies 4-6)
    Vassilena Tsvetkova
  • Clinical case: progression during NACT
    Luisa Carbongin
  • Clinical case: HR+/HER2-ve (1 premenopause, 1 postmenopause) to discuss HT+/-OFS and Extended HT
    Giacomo Pelizzari
  • Concluding comments
    Miguel Martin

 

SESSION VI – ADVANCED BREAST CANCER
Chairmen: Miguel Martin, Hope Rugo

New therapeutic algorithms

15.30

HR+ disease: what after failure of CDK4/6 inhibitors?
Stephen Johnston

15.50

HER2+ disease
Sandra Swain

16.10

Biopsy of metastases and ctDNA to guide treatment
Gabriel N. Hortobagyi

16.30

Q&A

16.45

Updates in immunotherapy for breast cancer
Peter Schmid

17.00

Adjourn

18.00

Ceremony for the presentation of the University of Padua Award for Advances in Breast Cancer 2019 and best poster award

18.15

Lecture of the Awardee

18.45

Cocktail

19.30

Adjourn

Saturday, October 12th

 

SESSION VII – ACTIONABLE PATHWAYS AND NEW DRUGS
Chairmen: Pierfranco Conte, Sybille Loibl

9.00

Multidisciplinary Tumor Board 3 – Management of Advanced Breast Cancer
Chairmen: Sandra Swain
Panelists: Jacek Jassem, Stephen Johnston, Philip Poortmans, Hoper Rugo

  • Clinical case: CDK4/6: Management of toxicity
    Carlo Alberto Giorgi
  • Clinical case: Brain disease or leptomeningeal disease
    Gaia Griguolo
  • Clinical case: Discordant phenotype
    Federica Miglietta
  • Clinical case: Visceral oligometastatic disease
    Giuseppe Buono
  • Concluding comments
    Sandra Swain

11.30

Coffee break

11.50

New promising drugs in development: special focus on AKT/PI3K inhibitors and PARP inhibitors
Giuseppe Curigliano

12.10

NGS in metastatic breast cancer: promises and pitfalls
Mafalda Oliveira

10.30

Q&A

13.00

Adjourn and final evaluation questionnaire

Participants can send one or more abstracts.

The form should be filled out by following specific guidelines:

  • Use the capitol letter for the title
  • Indicate each author's affiliation (that should include institution, department and town)
  • Underline the designated presenting author’s name.
  • Use font Times New Roman 10, single line spacing.

Abstracts will be selected by the Scientific Committee and will be shown during the poster session on October 11th from 8 am. Poster size: 90 cm wide and 120 cm high (portrait).

People sending the selected abstracts will have free registration, dinners and accommodation as well as a reimbursement of travel expenses (max of travel reimbursement € 200,00 for Italian participants and € 300,00 for European participants).

Abstracts should be sent within September 1st. A confirmation will be sent by email within September 7th.

Download Form

Send abstract

Fill out the form by entering the required information and the password that was provided to you (This email address is being protected from spambots. You need JavaScript enabled to view it.). Select the file of your abstract to attach it. ATTENTION: the only accepted format is Adobe PDF. The maximum file size is 2 MB.

Press "Send" to complete the operation.

Valore non valido

Valore non valido

Valore non valido

Valore non valido. Inserire SOLO numeri.

Valore non valido o estensione file non permessa

Valore non valido

You have to read the information on the processing of personal data for the form to be sent

Registration Fee

€ 250,00

€ 150,00 For graduate students and nurses

Tax free.

They includes the conference bag, the conference book and all coffee breaks and lunches. They do not include Hotel accomodation, dinners and travel expenses.

Click on the following button to open the on line registration form (in italian language):

Enroll

…or click on the following button for the application form in english (PDF document): download it, print it, fill it out manually and send it via fax to number +39.051.0569.162, within september 20th, 2019 (instructions inside):

Download registration form (PDF)

 

UNIVERSITY OF PADUA AWARD FOR ADVANCES IN BREAST CANCER 2019

The Scientific Committee will select young researchers (< 40 years from any country) who have published in an international peer-reviewed journal, as the principal author, a manuscript reporting important clinical or biological advances in breast cancer.
The winner will be invited to present his/her study during the annual Conference.

FELLOWSHIPS

Some fellowship (for under 40) will be awarded which will include registration and 3 Hotel nights.
Those interested should send the registration form together with a short CV and a motivation letter within July 21st.
The organizing secretariat will confirm the award of the fellowship within July 30th and it will proceed with the organization of logistics.

 

Under 40

Free admission is available for a few people “under 40”.
Registration forms will be accepted on a first-come, first-served basis until spaces will be full.
The Organization Secretariat will confirm the registration by email.

The slides of the 2018 meeting are now available.

Click here

Meeting Venue

Centro Congressi Villa Ottoboni, Padova.